Amparo Serna

597 total citations
10 papers, 349 citations indexed

About

Amparo Serna is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Amparo Serna has authored 10 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Amparo Serna's work include Prostate Cancer Treatment and Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Immunotherapy and Immune Responses (2 papers). Amparo Serna is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Immunotherapy and Immune Responses (2 papers). Amparo Serna collaborates with scholars based in United States, Colombia and Italy. Amparo Serna's co-authors include Corrado Caslini, James A. Connelly, Jay L. Hess, Dominique Broccoli, Oscar Orozco, Alberto Moreno, Luis J. Sigal, Andrea Biondi, Shivanshu Awasthi and Jasreman Dhillon and has published in prestigious journals such as The Journal of Immunology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Amparo Serna

8 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amparo Serna United States 6 159 126 81 71 61 10 349
Linglong Peng China 11 124 0.8× 50 0.4× 47 0.6× 21 0.3× 43 0.7× 33 288
Vijay Dasari United States 9 295 1.9× 39 0.3× 57 0.7× 30 0.4× 125 2.0× 11 460
Surya Amarachintha United States 13 191 1.2× 16 0.1× 68 0.8× 50 0.7× 36 0.6× 26 358
Anetta Sulewska Poland 12 210 1.3× 20 0.2× 43 0.5× 49 0.7× 59 1.0× 25 341
Bong-Kyeong Oh South Korea 10 229 1.4× 120 1.0× 22 0.3× 38 0.5× 27 0.4× 15 393
Yongfu Wang China 8 85 0.5× 21 0.2× 44 0.5× 36 0.5× 95 1.6× 23 270
Ruaa Al‐Qazazi Canada 7 151 0.9× 22 0.2× 63 0.8× 29 0.4× 125 2.0× 9 310
Kumi Nagao Japan 10 182 1.1× 175 1.4× 33 0.4× 21 0.3× 22 0.4× 18 343
Gerard te Meerman Netherlands 9 81 0.5× 21 0.2× 81 1.0× 92 1.3× 52 0.9× 15 296
Gülay Güleç Ceylan Türkiye 9 149 0.9× 49 0.4× 43 0.5× 19 0.3× 26 0.4× 34 268

Countries citing papers authored by Amparo Serna

Since Specialization
Citations

This map shows the geographic impact of Amparo Serna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amparo Serna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amparo Serna more than expected).

Fields of papers citing papers by Amparo Serna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amparo Serna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amparo Serna. The network helps show where Amparo Serna may publish in the future.

Co-authorship network of co-authors of Amparo Serna

This figure shows the co-authorship network connecting the top 25 collaborators of Amparo Serna. A scholar is included among the top collaborators of Amparo Serna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amparo Serna. Amparo Serna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
El-Kenawi, Asmaa, Shivanshu Awasthi, Amparo Serna, Jasreman Dhillon, & Kosj Yamoah. (2022). ANPEP: A Potential Regulator of Tumor Cell—Immune Metabolic Interactions in Prostate Cancer of Men of African Descent. JCO Global Oncology. 8(Supplement_1). 52–52. 3 indexed citations
3.
Yamoah, Kosj, et al.. (2022). RF05 | PSUN358 ANPEP: A potential regulator of tumor cell - macrophage metabolic interactions in prostate cancer of African American men. Journal of the Endocrine Society. 6(Supplement_1). A892–A893.
4.
El-Kenawi, Asmaa, William Dominguez‐Viqueira, Min Liu, et al.. (2021). Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer. Cancer Research. 81(21). 5477–5490. 68 indexed citations
5.
Awasthi, Shivanshu, Anders Berglund, Robert J. Rounbehler, et al.. (2020). Comparative Genomics to Uncover Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). S120–S121.
6.
Ma, Xueying, Amparo Serna, Ren-Huan Xu, & Luis J. Sigal. (2009). The Amino Acid Sequences Flanking an Antigenic Determinant Can Strongly Affect MHC Class I Cross-Presentation without Altering Direct Presentation. The Journal of Immunology. 182(8). 4601–4607. 12 indexed citations
7.
Caslini, Corrado, James A. Connelly, Amparo Serna, Dominique Broccoli, & Jay L. Hess. (2009). MLL Associates with Telomeres and Regulates Telomeric Repeat-Containing RNA Transcription. Molecular and Cellular Biology. 29(16). 4519–4526. 103 indexed citations
8.
Caslini, Corrado, Amparo Serna, V Rossi, Martino Introna, & Andrea Biondi. (2004). Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. Leukemia. 18(6). 1064–1071. 25 indexed citations
10.
Orozco, Oscar, et al.. (1997). Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition. 13(10). 878–881. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026